trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['breast']
breast cancer advocates: interested in learning more about tdxd and her2-low? sign up for group 5e of grasp #asco22 poster walkthroughs for a small group discussion about these two posters with &amp; . only 1 spot remains!! 
Together, patients & cancer researchers can advance more breakthroughs #GRASPcancer #Oncoalert